Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,876,825 papers from all fields of science
Search
Sign In
Create Free Account
MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2
Known as:
MAP Kinase Signal-Integrating Kinase 2
, Mnk2
MAP kinase-interacting serine/threonine-protein kinase 2 (465 aa, ~52 kDa) is encoded by the human MKNK2 gene. This protein may be involved in…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
CDC7 protein, human
CDK10 protein, human
Enzyme Gene
MAPKinase Signaling Pathway
Expand
Broader (1)
Protein-Serine-Threonine Kinases
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 3855: Inhibition of MNK by eFT508 reprograms T-cell signaling to promote an antitumor immune response
C. Stumpf
,
Joan W Chen
,
+4 authors
K. Webster
Experimental and Molecular Therapeutics
2018
Corpus ID: 81133116
Mitogen-activated protein (MAP) kinase signaling cascades play a vital role in T-cell activation upon antigen recognition. MNK1…
Expand
2018
2018
Abstract 5546: eFT508, a potent and highly selective inhibitor of MNK1 and MNK2, regulates T-cell differentiation promoting an antitumor immune response
R. Sharma
,
V. Goel
,
+5 authors
K. Webster
Immunology
2018
Corpus ID: 81182451
An effective and durable T-cell response is a cornerstone of current immunotherapies. We show that eFT508, a potent, selective…
Expand
2017
2017
Abstract 596: eFT508, a potent and highly selective inhibitor of MNK1/2 regulates immune checkpoint and cytokine expression promoting anti-tumor immunity
K. Webster
,
V. Goel
,
+15 authors
S. Reich
2017
Corpus ID: 79953680
Dysregulated translation of messenger RNA (mRNA) plays a role in the pathogenesis of multiple solid tumors and hematological…
Expand
2017
2017
A Phase 1-2 Dose-Escalation and Cohort- Expansion Study of eFT508, a Selective, Orally Bioavailable Inhibitor of MNK1 and MNK2, in Patients with Hematological Malignancies
A. Gopal
,
R. Ramchandren
,
+10 authors
J. Barton
2017
Corpus ID: 198297361
Introduction Dysregulated translation of messenger RNA (mRNA) plays a role in the pathogenesis of multiple hematological and…
Expand
2017
2017
MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer
Z. Guo
,
G. Peng
,
+7 authors
Jianxing He
Scientific Reports
2017
Corpus ID: 256897092
We hypothesized that MAP kinase-interacting serine/threonine kinase 2 (MNK2) may contribute to non-small cell lung cancer (NSCLC…
Expand
2016
2016
Sulfoximine substituted quinazolines for pharmaceutical compositions US 20150005278 (A1): a patent evaluation
Kaalin Gopaul
,
N. Koorbanally
Expert Opinion on Therapeutic Patents
2016
Corpus ID: 41341542
ABSTRACT Mnk1 and Mnk2 are protein kinases responsible for phosphorylating eIF4E, a eukaryotic initiation factor responsible for…
Expand
2016
2016
Mnk1 and mnk2 isoindoline, aza isoindoline, dihydroindolyl Denon and dihydro-aza-in Denon inhibitors
ポール・エイ・スプレンゲラー
,
ジークフリート・エイチ・ライク
,
+4 authors
チン・トラン
2016
Corpus ID: 149709138
The present invention provides compounds represented by Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable…
Expand
2015
2015
Dynamical insights of Mnk2 kinase activation by phosphorylation to facilitate inhibitor discovery.
Malika Kumarasiri
,
Theodosia Teo
,
Shudong Wang
Future Medicinal Chemistry
2015
Corpus ID: 26373888
AIM Mitogen-activated protein kinase-interacting kinases (Mnks) are emerging anticancer targets. Mnks feature unique structural…
Expand
Highly Cited
2007
Highly Cited
2007
MNK1 and MNK2 Regulation in HER2-overexpressing Breast Cancer Lines*
C. Chrestensen
,
J. Shuman
,
A. Eschenroeder
,
M. Worthington
,
H. Gram
,
T. Sturgill
Journal of Biological Chemistry
2007
Corpus ID: 29654196
MAPK-interacting protein kinases 1 and 2 (MNK1 and MNK2) function downstream of p38 and ERK MAPK, but there are large gaps in our…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE